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•    Introduction    • 
 
  
 Even before the discovery that genes were encoded on DNA and 
the subsequent discovery of the double-helical structure of DNA, the 
question of how we inherit our traits has been studied.  Hippocrates, a 
Greek physician c.a. 400 B.C., was the first to propose a model of how 
traits are inherited.1  Since that time, many discoveries have fleshed out 
our understanding of how genes are regulated to form a pattern of 
inheritance.  We now understand DNA is compacted through a 
mechanism involving histones, which are basic proteins containing a 
great number of modifiable residues.  DNA wraps around a nucleosome 
core particle, which is an octamer formed with two of each of the histone 
proteins: H2A, H2B, H3, and H4 (Figure A-1a).2   
The level of DNA compaction fluctuates between a 
transcriptionally 
silenced 
heterochromatin 
state and a 
transcriptionally 
active 
euchromatin 
state (Figure A-
1b; 
Figure A-1: 
(a) The structure of the nucleosome core particle 
as taken from Luger, K. et al. (1997). Nature 
398, 251-260. 
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obtained from http://dellairelab.medicine.dal.ca/images/chromatin.jpg ).3  
The exact mechanism by which heterochromatin is interconverted to 
euchromatin, and thus which genes are being actively transcribed, is not 
fully known.   
It is known that covalent modifications on histones play a profound 
role in regulating DNA replication, transcription, and heterochromatin 
gene silencing.  In the subsequent sections, the overarching question to 
be addressed is “How are histones, and thus gene transcription, 
(b) Chromatin compaction occurs when DNA wraps around histone 
proteins.  
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regulated?”  The first section of the Capstone Project seeks to analyze 
this question by asking “How do modifiable histone residues affect 
lifespan?”  Also, we ask, “Besides their known roles in chromatin biology, 
do histones affect cell aging?”  The second section analyzes two 
proteins, the Mixed Lineage Leukemia (MLL) protein in humans and the 
SET1 protein in Saccharomyces cerevisiae, which are involved in 
determining the chromatin architecture through the addition of covalent 
modifications onto histones.  Here, we ask “How do these two proteins 
epigenetically regulate transcription by catalyzing the methylation of 
lysine 4 of histone H3?”  Also, what mechanisms are in place to regulate 
their enzymatic activity, and thus chromatin structure? 
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•    Chronological Life-Span Analysis of Histone H2B Mutants    • 
 
 
INTRODUCTION 
 
 The mechanism of chromatin modification is central to the 
regulation of transcriptional activity.4-5  The fundamental unit is a 
nucleosome composed of histones H2A, H2B, H3, and H4 joined in an 
octamer.  Chromatin, within the eukaryotic genome, is found in two 
states; heterochromatin, an inaccessible form which is transcriptionally 
repressive, and euchromatin, an accessible form which is 
transcriptionally permissive.  Conversion between these two states is 
regulated by ATP-dependent nucleosome-remodeling complexes which 
shift the positions of individual nucleosomes and post-translational 
histone modifications that serve to recruit the binding of particular 
proteins.6-7   
One important model used to analyze how gene expression is 
regulated is Saccharomyces cerevisiae, commonly known as baker’s 
yeast.  Yeast have three silenced regions in their genome: the telomeres, 
ribosomal DNA (rDNA), and the silent mating loci (HMR loci).8  By 
inserting reporter genes into these silenced regions, screens have been 
developed which permit one to identify particular histone mutants that 
change a particular silencing phenotype.  One screen developed by 
Smith and coworkers has a reporter gene for URA3 inserted into the 
rDNA regions (Figure B-1).9  When a reporter gene is located within a 
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Figure B-1: Representation of the 
rDNA structure with location of each 
reporter gene.  Adapted from Figure 
1A in Smith et al. (1999).  
Molecular and Cellular Biology.  
19 (4): 3184.  
 
silenced region, the yeast are unable to grow on uracil-deficient plates.  If 
a particular mutant is able to grow on the URA-deficient plates, it can be 
concluded that the mutation 
has resulted in a loss of rDNA 
silencing.  Silencing using the 
URA3 marker can also be 
assayed by growing the yeast 
on 5-fluoro-orotic acid (5-FOA) 
plates, which is deadly for cells 
expressing URA3 (i.e. when 
URA3 is not being silenced).10   
Although modifications 
Figure B-2: Histone H2B mutant library.  Conserved lysine and 
arginine residues were selected because they are known to be 
modifiable amino acids.  Boxes indicated residues chosen to be 
mutated.   
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Figure B-3: Mapping of R87A and R102A mutants on the yeast 
nucleosome core particle.   
 
(a) Surface view of the yeast nucleosome core particle 
(Brookhaven PDB [1lD3].  Mutated resides are show in pink. 
 
on histone H3 and H4 have been extensively studied, relatively few 
modified sites on histones H2A and H2B are known.  Dai and coworkers 
have systematically mutated possible modifiable resides on histone H2B 
to mimic both the modified and unmodified states (Figure B-2).  Further 
analysis of these mutations by Dai has shown that there are two arginine 
mutants on histone H2B, R95A and R102A (Figure B-3), which play a  
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(b) Alternate view of the yeast nucleosome core particle (Brookhaven 
PDB [1lD3].   
 
(c) Close-up of mutated 
resides.
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Figure B-4:  
(a) For each reporter gene, various assays help to determine the 
silencing state.   
 
(b) rDNA silencing quantitative growth assay.  Ten-fold serial 
dilutions of freshly grown yeast cells plated onto either SC 
Complete (N/S: Non-selective) or medium containing 5-FOA.  
Plates were grown at 30°C for 2 days and then photographed.  
Arg95 mutants increase rDNA silencing while R102A mutants 
decrease rDNA silencing. 
 
 distinct role in regulating telomeric and rDNA silencing (Junbiao Dai and 
Jef Boeke, personal communication).  Reference to Figure B-4a is 
helpful to determine silencing state based on assays.   
The strain containing the R95A H2B mutation grows on uracil-  
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(b) Telomeric silencing strain: A genetic screen for telomeric 
silencing mutants uses the following strain with URA3 and ADE2 
reporter genes within the telomeres. 
 
 
 
(c) Quantitative growth assay used to determine telomeric silencing.  
Ten-fold serial dilutions of freshly grown yeast cells plated onto either 
SC Complete (N/S: Non-selective), SC-URA, or medium containing 
5-FOA.  Plates were grown at 30°C for 2 days and then 
photographed.   
(d) Quantitative colony color assay used to determine telomeric 
silencing.  Ten-fold serial dilutions of freshly grown yeast cells plated 
onto SC complete media.  The colony color was determined after the 
plates had been incubated at 30°C for 2 days and then stored at 4°C 
for 1 week.  
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deficient plates, suggesting that telomeric silencing was lost (Figure B-
4d,e).  In contrast, rDNA silencing was enhanced in the strain bearing 
the R95 H2B mutation (Figure B-4b).  Conversely, in the strain bearing 
the R102A H2B mutation, rDNA silencing was lost (Figure B-4b) while 
telomeric silencing was increased (Figure B-4de).  Also, R102A 
displayed increased levels of extra-chromosomal rDNA circles, similar to 
what was observed when sir2p, a silent information regulator protein 
crucial for rDNA silencing, was deleted.11   
This finding is significant in that increased accumulation of ERC’s 
has been implicated in shorting yeast replicative life span, thus 
suggesting that histones are involved in aging.12  The replicative lifespan 
is determined by counting the maximum number of buds the mother cell 
generates through multiple rounds of cell division.13  After each round of 
division, ERCs excise from yeast rDNA repeats and accumulate 
asymmetrically in the mother cell.14  Although replicative lifespan is 
different from chronological life-span (CLS), which is defined as the 
“measure of the length of time a population of yeast organisms remains 
viable under non-dividing conditions,”15 it has been suggested that the 
mechanisms regulating chronological and replicative lifespan might be 
similar.16,17  
From the increased levels of ERC’s in H2B R102A strain, it is 
likely that replicative lifespan has been shortened.  Though both 
lifespans have similar mechanisms, this does not suggest that CLS 
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should also be shortened.  As mentioned earlier, sir2p has also been 
found to increase levels of ERCs.  However, recent research has begun 
to question whether sir2p is involved in aging.18,19  Considering the 
distinct roles of H2B residues R95 and R102 in regulating telomeric and 
rDNA silencing, the question arises as to whether histones are involved 
in aging rather than the regulators of silencing (such as sir2p).  We 
wished to test that hypothesis and determine whether these mutants 
caused any changes in the CLS of yeast.   
 
METHODS 
Nucleosome views  
Nucleosome views (Figures B-3: a, b, and c) were generated 
using PyMOL.20  Yeast nucleosome core particle PDB file 1id3.21 
Chronological Lifespan Assay (CLS) 
 The CLS assay, developed by Fabrizio and Longo, determines the 
survival of non-dividing yeast populations under two conditions22.  The 
first condition is one of high metabolism where the yeast are grown in a 
nutrient rich medium (SDC) while the second is a low metabolism 
stationary phase which is induced when the yeast are grown in water.  
When grown in water, conditions of hyper caloric restriction replicate a 
state of extreme starvation found in nature and allow the yeast to survive 
longer than in SDC.23   
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The following protocol was followed:   The strains were streaked 
onto YPD plates and allowed to grow for 2 days at 30°C (Figure B-5).  
Four colonies per strain 
were selected and 
independently inoculated 
into 2 mL of SDC media 
overnight.  The overnight 
cultures were then diluted 
to an OD600 of 0.1 in 20 
mL of SDC (day zero).  
The 50 mL flasks were 
incubated at 30°C with 
shaking at 220 rpm.  On 
day three, two of the SDC 
cultures were harvested in sterile Polypropylene tubes by centrifuging at 
3000rpm for 5 minutes.  The pellet was then resuspended in 20 ml of 
sterile water and washed two more times.  Then, the cells were 
resuspended in 20 ml of water and returned to the original flask.   
Subsequently, two 10 µl aliquots per culture (for both SDC and 
water cultures) were removed to measure the ability of the yeast to form 
a colony (or colony forming units, CFUs).  Two aliquots were used per 
culture to reduce the variation due to manual error.  The aliquots were 
serially diluted 1: 10 with sterile water in a 96-well clear flat bottom plate.  
 
 
Figure B-5: Schematic representation of 
CLS assay.  Obtained directly from  
Figure One of Parrella, E., and Longo, V. 
(2008).  Methods 46, 257.  
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Then 10 µl from the 10-4 dilutions were plated onto YPD plates and were 
grown for 2 days (and then counted and imaged).  The CFU’s counted 
from day three is the initial survival rate (100%).  The CFUs were 
measured every two days thereafter and lower dilutions were plated as 
the mortality rate increased.  The experiment continued until survival 
reached 1% and a record of the date, dilution factor, the colony count 
and the volume spread was made for each plate.  From this record, the 
number of CFU’s was calculated and plotted against the number of days 
elapsed.  
 
RESULTS 
 
The CLS experiment with the histone mutants was repeated two 
times.  The first time the experiment was attempted, contamination of the 
cultures washed with water prevented the completion of the experiment.  
Yeast grown in SDC had no contamination, likely due to minimal 
manipulation of the yeast.  However, the yeast cultures grown in water 
had a high risk of contamination due to the washing steps.  We then 
augmented our experimental design by changing the glassware with 
which the cultures were grown.  Instead of using 50ml Erlenmeyer flasks, 
which make it harder to transfer the cultures into a sterile polypropylene 
tube, we grew the cultures in 18mm glass test tubes in rotating drums at 
full speed.   
As presented before, there are two arginine mutants on histone 
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Figure B-6: Rational for using rim15∆ and sch9∆ as controls in 
CLS experiments.  Figures are adapted from the graphs found in 
Figure 2 of Fabrizio and coworkers (2001) Science 292, 288-290 
 
 (a)  In previous CLS experiments, rim15∆ has been shown to 
greatly reduce lifespan compared to wildtype.   
 
(b) Likewise, sch9  has been shown to greatly extend lifespan 
compared to wildtype yeast.   
 
 
H2B (R95 and R102), which play distinct roles in regulating telomeric 
and rDNA silencing. For the experiment, we wanted to test if these 
mutants changed the chronological lifespan in yeast.  We used two 
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controls for our experiment, sch9  and rim15 .  Sch9 has been 
shown in previous experiments to greatly extend CLS, while rim15∆ has 
been shown to decrease CLS compared to wild type (Figure B-6 a, b; 
adapted from the graphs found in Figure 2 of Fabrizio and coworkers).24   
Besides the two positive controls, JDY78 wild type, F7 in strain 
JDY78 (R95A), F9 (R102A), and 78-142 (a double mutant of 
R95A/R102A) were assayed.  Our results can be seen in Figure B-7.  
Figure B-7: The following experiment was performed in water (a 
state of severe caloric restirction) by switching the cells from SDC to 
water after the population reached saturation.  R102A was found to 
extend lifespan.   
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Compared to wild type, both the R95A/R102A double mutant and the 
R102A mutant had increased chronological life span.   On the other 
hand, R95A had no extension of lifespan compared to wild type.   
Likewise, R102A had increased lifespan when compared to our long 
lived control, sch9 .  From this data, we conclude that alanine 
substitution of Arg102 greatly extends chronological life span.   
 
DISCUSSION 
 
 
In the H2B R95A strain, telomeric silencing is lost while the rDNA 
silencing is enhanced.  In contrast, in the H2B R102A strain, the rDNA 
silencing is lost while the telomeric silencing is increased.   R102A also 
displayed increased levels of extra-chromosomal rDNA circles, similar to 
what was observed when histone deacetylase sir2p, a silent information 
regulator protein crucial for rDNA, telomeric, and HMR silencing, was 
deleted.   Because increased levels of ERC’s have been implicated in 
decreased replicative lifespan, it would seem that sir2p and thus histones 
are involved in aging.   
However, recent work has begun to challenge the notion that the 
sir2p extends the replicative life-span.25,26   Instead, it has been 
suggested that caloric restriction increases lifespan via sch9, which acts 
in glucose-dependent signaling and stimulates growth and glycolysis.27,28 
It has therefore been questioned whether histones are involved with 
aging.  We found that R95A did not extend lifespan compared to wild 
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type suggesting that the increased CLS of the R95A/R102A double 
mutant is likely due to the R102A mutation rather than an effect due to 
R95A.   
Nevertheless, R102A increased lifespan when compared to 
sch9 , which had previously been found to extend lifespan up to three 
times when compared to wild-type.  It is significant that R102A extended 
the lifespan by an amount greater than sch9∆.  However, why would 
H2B R102A strain increase CLS when the strain was found to increase 
accumulation of ERCs that have been implicated in shorting yeast 
replicative life span?  Though the replicative lifespan and CLS are 
regulated similar mechanisms, this does not suggest that a CLS assay 
should yield the same result as the replicative lifespan.  An example is a 
mutation made by Fabrizo and coworkers which decreased CLS, but 
extended replicative life span.29  
Although it is difficult to understand the mechanism by which 
R102A extends lifespan, perhaps the unique profile of decreased rDNA 
silencing while increasing telomeric silencing plays a role.  Though the 
preliminary data ought to be replicated to further support these claims, 
we tentatively conclude that alanine substitution of Arg102 greatly 
extends chronological life span and suggests that in addition to their 
known roles in chromatin biology, histones may, directly or indirectly, be 
involved in aging.  
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•    Characterization of the Human Mixed Lineage Leukemia  
Protein homolog SET1 in Saccharomyces cerevisiae    • 
 
INTRODUCTION 
Mixed Lineage Leukemia (MLL) is a protein involved in positively 
regulating the transcription of homeobox (HOX) genes, which play 
significant roles in animal development and homeostasis.  MLL 
epigenetically regulates transcription by catalyzing the methylation of 
lysine 4 of histone H3, which has been demonstrated to stimulate the 
recruitment of chromatin-remodeling factors and histone-modifying 
enzymes.30  When MLL is rearranged in human leukemias, deregulated 
HOX genes are overexpressed, resulting in aggressive lymphoid and 
myeloid acute leukemias.31 
Previous work in the Cosgrove lab has made important progress 
in understanding the structure and function of MLL in vitro.  In particular, 
recent experiments in the lab have shown that WDR5 (WD-repeat 
protein-5), a member of the conserved core group of proteins that 
regulate MLL’s methyltransferase activity, recognizes a conserved motif- 
called the “Win” or the WDR5 interaction motif.32  This motif contains a 
crucial arginine residue (3765), which is essential for the assembly of the 
core complex in vitro (see figure C-133).  Furthermore, it has been shown 
to be key for MLL’s enzymatic activity.34  The next important step 
towards understanding the function of residue R3765 is to understand 
the alanine mutation affects how this protein works in vivo.   
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Saccharomyces cerevisiae, a simple unicellular eukaryote, is a 
great model organism with which to study these results in vivo.  We will 
be looking at MLL’s homolog in yeast, called SET1.  Similar to MLL, 
SET1 assembles a conserved complex of proteins that regulate histone 
methylation and gene expression in yeast.35  Both SET1 and MLL 
catalyze the methylation of lysine 4 of histone H3 and when the SET1 
gene in S. cerevisiae is deleted, all H3K4 methylation is eliminated. 36,37   
While the mechanism for regulating H3K4 methylation is 
unknown, two other mutants (besides the R3745) have been identified to 
change the methylation state of H3K4 catalyzed by MLL.  One of these 
mutations is a tyrosine to a phenylalanine at residue 3942 of MLL, which 
has been shown to change MLL’s product specificity from primarily being 
a monomethyltransferase to a trimethyltransferase.38  The other mutation 
Figure C-1: Taken from Figure 1 of Patel et al. (2008). Structure of 
WDR5 Bound to Mixed Lineage Leukemia Protein-1 Peptide* 
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is N3906A, which interferes with the binding of the cofactor SAM and has 
been shown to abolish catalytic activity of MLL.39   The goal of my 
research is to biochemically characterize the lysine 4 methylation state of 
these three MLL mutants in S. cerevisiae SET1p protein (Figure C-2).   
 
 
METHODS 
 
Primers for Polymerase Chain Reaction (PCR) and Mutagenesis 
 
 Oligonucleotide primers (5’-3’) used: 
N1016A forward: GCC CGT TTC AAT GCT CAT TGT TGT GAT CC 
N1016A reverse: GGA TCA CAA CAA TGA GCA ATG AAA CGG GC 
R871A forward: CAC AAT GAA GCG AAT GAG TAC ACA CC 
Figure C-2: Expected outcomes for each SET1 mutant.  R871A is 
the predicted homologous amino acid of R3765A mutant in MLL; like 
R3745A, we expect mono-methylation of H3K4 when R871 is 
mutated to alanine.  The second mutant is Y1052F which we predict 
to be homologous to amino acid Y3942 of MLL and is predicted to 
change MLL’s product specificity from primarily a 
monomethyltransferase to a trimethyltransferase. The third mutation 
in SET1 is N1016A which is the predicted homolog of N3906A of 
MLL, which we predict to interfere with the binding of the cofactor 
SAM, and to abolish the catalytic activity of MLL. 
 
Mutant 
Expected 
Silencing 
phenotype  
Expected 
euchromatic gene 
expression  
Expected 
H3K4 
methylation  
R871A  Normal  defective  mono  
N1016A  
like SET1 
knockout  like SET1 knockout  decreased  
Y1052F  
strong loss of 
silencing  increased  
trimethylation 
everywhere  
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R871A reverse: GGT GTG TAC TCA TTC GCT TCA TTG TG 
Y1052F forward: GCG AAG AGT TGA CAT TTG ATT ACA 
Y1052F reverse: TGT AAT CAA ATG TCA ACT CTT CGC 
 
Plasmids and Mutagenesis  
 To determine the homologous MLL residues in SET1, a BLAST, 
Basic Local Alignment Search Tool, search was conducted.  Using this 
search, we decided to make the following mutations in SET1: N1016A, 
R871A, and Y1056F. The homologous mutations have been shown in 
MLL to decrease H3K4 methylation, cause mono-methylation of H3K4, 
and cause tri-methylation of H3K4, respectively.  The first step was to 
make the mutations using Stratagene’s QuikChange® Site-Directed 
Mutagenesis Kit.40  Site-directed mutagenesis is a technique that can be 
used to create point mutations, 
deletions and insertions using a 
double-stranded plasmid.   
A wild-type PRS315-SET1 plasmid 
was obtained from Michael 
Cosgrove for the mutagenesis 
(Figure C-3).  Two oligonucleotide 
primers, each being 
complementary to the opposite stand of the vector, containing the 
mutation were ordered for each mutagenesis (Figure C-441).  Upon the 
Figure C-3: Schematic 
representation of PRS315-SET1 
plasmid.   
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primers annealing to the plasmid, the strands are extended during a 
polymerase chain reaction (PCR) using PfuTurbo DNA polymerase.  This 
forms unmethylated, mutated plasmids with staggered nicks.  After the 
PCR reaction, Dpn I is added to digest the methylated parental DNA, 
leaving only the mutated vector.  This vector is then transformed into  
Figure C-4: Schematic representation of site-directed mutagenesis 
procedure as adapted from Figure 1 of Stratagene’s QuikChange® 
Site-Directed Mutagenesis Kit INSTRUCTION MANUAL.   
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Stratagene’s XL1-Blue supercompetent cells and plated onto LB-
carbenicillin plates to select for bacteria which have the plasmid.   
 
Plasmid Sequencing 
 
Although ideally the mutagenesis should only result in one 
mutation, the entire plasmid must be sequenced to verify that no other 
mutations were made.  Current fluorescent dye-terminator sequencing 
technology allows about 900 nucleotides to be sequenced per 
sequencing run.  Sequencing technology is a modified PCR reaction.  In 
each sequencing reaction, besides the vector to be sequenced and DNA 
polymerase, four deoxynucleotides (dATP, dGTP, dCTP, and dTTP) are 
added to the reaction.42   
Sequencing differs from a PCR reaction in that four fluorescently 
labeled dideoxynucleotides (ddNTPs) are also added.  These ddNTPs 
are missing the 3’ hydroxyl group necessary to extend the DNA chain, 
therefore terminating the reaction.  After the modified PCR reaction is 
complete, the resulting DNA strands have different lengths and can be 
separated via capillary electrophoresis (see figure C-5a43).  Each of the 
ddNTPs has a different wavelength at which they fluoresce.  Different 
nucleotides can then be identified at the end of the capillary by 
measuring the wavelength fluoresced upon laser excitation (Figure C-
5b).   From the peaks, a read out of the complementary DNA sequence 
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Figure C-5: Fluorescent dye-terminator DNA sequencing  
(a) Sequencing technology is a modified PCR reaction containing 
the vector to be sequenced, DNA polymerase, four 
deoxynucleotides (dATP, dGTP, dCTP, and dTTP), and four 
fluorescently labeled dideoxynucleotides (ddNTPs).  The 
ddNTPs are missing the 3’-OH group necessary to extend the 
DNA chain, therefore terminating the reaction.  After the 
modified PCR reaction is complete, the resulting DNA strands 
have different lengths that can be separated via capillary 
electrophoresis as they move from a negatively charged buffer 
to a positively charged buffer.  The fluorescent ddNTPs emit 
different wavelengths of fluorescence upon laser excitation 
and the measured wavelength is detected and recorded.   
From the peaks, a read out of the complementary DNA 
sequence is generated and can be compared to the known 
sequence of the plasmid insert to verify the mutation.  About 
900 nucleotides are usually sequenced per run.  Figure 
adapted from http://dnasequencing.files.wordpress.com/2007/ 
10/ ce_basic.jpg 
 
 
 
(b) Section of DNA chromatograph:  The peaks of each color 
correspond to a particular labeled nucleotide.   
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 is generated and can be compared to the known sequence of the 
plasmid insert to verify the mutation.   
Yeast Strains 
Yeast strain JDY137 was used to test rDNA silencing using mHIS3-
URA3 marker at NTS2; YNB9 with set1∆ (Figure C-6a). Yeast strain 
JDY164 was used to test HMR silencing with hmrDA::TRP1 marker; 
BY5001 with set1 ∆ (Figure C-6b).  Yeast strain JDY165 was used to 
test telomeric silencing with URA3 and ADE2 inserted in the telomeric 
region, BY5024, also named UCC3505, with set1 ∆ (Figure C-6c).  All 
strains are selected by growing on synthetic media lacking leucine.   
 
 
Figure C-6:  
(a) Schematic representation of yeast strain JDY137 which was 
used to test rDNA silencing using mHIS3-URA3 marker at 
NTS2 (YNB9 with set1∆).  Adapted from Figure 1A in Smith et 
al. (1999).  Molecular and Cellular Biology.  19 (4): 3184. 
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Silencing Assays 
After the three plasmids were sequenced, the plasmids were sent 
down to Jef Boeke and Junbiao Dai, our collaborators at Johns Hopkins 
Medical Institute to be transformed into yeast set1∆ strains.  For each 
(b)  Representation of strain JDY164 used to test HMR silencing with 
hmrDA::TRP1 marker (BY5001 with set1∆).  
 
 
(c) Schematic representation of strain JDY165 that is used to test 
telomeric silencing with URA3 and ADE2 at telomeric region 
(BY5024, also named UCC3505, with set1∆). 
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 plasmid, two independent transformations per strain were done for three 
different yeast set1∆ backgrounds (Figure C-7).  Each strain has various 
reporter genes which allow the silencing level to be assayed.   
The reporters used are URA3, ADE2, TRP1, and mHIS3-URA3.  
For strains containing either the URA3 or mHIS3-URA3 reporter genes, 
the level of silencing is determined using the following two assays.  First, 
the yeast are plated onto uracil-deficit plates (SC-URA).  When the 
URA3 reporter gene is silenced, the yeast are unable to grow.  Silencing 
using the URA3 marker can also be assayed by growing the yeast on 5-
fluoro-orotic acid (5-FOA) plates, which is deadly for cells expressing 
URA3 (i.e. when URA3 is not being silenced).44   
Figure C-7: Two independent transformations of each plasmid per 
strain.  Yeast strain JDY 137 was used to assay rDNA silencing; strain 
JDY164 was used to test HMR silencing; strain JDY165 was used to 
test telomeric silencing.  Note: Each strain is selected by plating onto 
SC-LEU plates.  Plates were incubated at 30°C for 2 days and then 
photographed.   
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For strains with the ADE2 reporter genes, if ADE2 is being 
silenced, cells build up a chromogenic intermediate that gives the yeast 
colonies a red color.45  For cells that are expressing ADE2, the colonies 
are white in appearance.  Silencing can also be assayed with the TRP1 
marker by checking the ability of the yeast to grow on synthetic media 
lacking tryptophan (SC-TRP). 
After transformation, telomeric, rRNA, and HM loci silencing was 
assayed.  For each assay, cells were grown overnight at 30°C on a roller 
drum at top speed and were diluted to OD600 =1.0.  Subsequent ten-fold 
serial dilutions were plated onto both non-selective media and selective 
media.  After the plates were incubated at 30°C for 2 days, photographs 
were taken. For telomeric silencing assays using the ADE2 marker, the 
colony color was assayed after the plates were incubated at 30°C for 2 
days and then stored at 4°C for 1 week. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C-8: For each reporter gene, different assays 
can be performed.  Silencing level can be determined 
from chart below.     
30 
 
RESULTS 
 
 In order to examine if R871A, N1016A, and Y1052F are important 
for the function of SET1, they were transformed into three different yeast 
set1∆ strains and plated onto selective media for the silencing assays, 
as described in Methods: Silencing Assays (refer to Figure C-8 for 
interpretation of silencing assays).  Our rDNA silencing data suggests 
that R871A has approximately the same level of rDNA silencing as the 
wild type strain (Figure C-9).   N1016A has decreased rDNA silencing, 
Figure C-9: rDNA silencing assayed for quantitative growth.  
Photographs were taken after 2-3 day incubation at 30°C. assay.  
Ten-fold serial dilutions of freshly grown yeast cells plated onto both 
SC-LEU (Non-selective for assay; used to check growth of yeast) and 
medium containing 5-FOA.   
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much like the set1∆ strain.  Y1052F appears to have increased rDNA 
silencing.   
 On the other hand, our HMR silencing assay data was 
unconclusive (Figure C-10).  Although one of the R871A transformants 
appears to have decreased HMR silencing, the other transformant 
appears to have increased HMR silencing.  N1016A appears to have 
increased silencing, much like set1∆.  Y1052F appears have the same 
level of silencing as the wildtype.  Likewise, our telomeric silencing did 
Figure C-10: HMR silencing assayed for quantitative growth.  
Photographs were taken after 2-3 day incubation at 30°C. Ten-
fold serial dilutions of freshly grown yeast cells plated onto both 
SC-LEU and SC-LEU-TRP.   
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not provide any conclusive results based on the colony color assay 
(Figure C-11).   
 
DISCUSSION 
 When the results were received from our collaborators, most of 
the actual silencing phenotypes did not line up with our expected results 
(Figure C-12).  We then returned to the literature to examine if our 
Figure C-11: Telomeric Silencing Assay: Quantitative colony color 
assay used to determine telomeric silencing.  Ten-fold serial dilutions 
of freshly grown yeast cells plated onto SC complete media.  The 
colony color was determined after the plates had been incubated at 
30°C for 2 days and then stored at 4°C for 1week.  
 
 
 
Figure C-12: Expected outcomes for each SET1 mutant and 
compared to results.   
Mutant 
Expected 
Silencing 
phenotype  
Observed 
rDNA 
silencing  
Observed 
HMR 
silencing  
 
Observed
Telomeric 
silencing 
R871A  Normal Normal inconclusive Normal 
N1016A  Like set1∆ Like set1∆ Like set1∆ Normal 
Y1052F  
strong loss of 
silencing 
Increased 
silencing Normal 
 
Normal 
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results matched with respect to the different silencing phenotypes 
between the set1∆ and the wild type.  Previous research by Bryk and 
coworkers has shown that SET1 regulates rDNA silencing in yeast.46  In 
set1∆ strains, they found that expression of URA3 is approximately 100-
fold higher than in wild type (Figure C-13a).  This result is consistent with 
our data for rDNA silencing (Figure C-13b).    
 Thus, it is possible that our results for the rDNA silencing assay 
are valid.  Our rDNA silencing data suggested that R871A has 
approximately the same level of rDNA silencing as the wild type strain, 
which is what we expected if the R871A mutation resulted in mono-
methylation of H3K4.   As expected, N1016A has decreased rDNA 
silencing, much like the set1∆ strain.  However, we are surprised that 
Figure C-13:  
(a) Expected rDNA silencing phenotypes for SET1 and set1∆. 
Adapted from Figure 1c of Bryk and coworkers (2002).  
 
(b) Observed rDNA silencing phenotype for SET1 and set1∆. 
 
34 
 
Y1052F appears to have increased rDNA silencing.  We expected 
Y1052F to change SET1’s enzymatic activity from a mono-
methyltransferase to a tri-methyltransferase.  Because trimethylation of 
H3K4 has been associated with active genes, we expected a loss of 
rDNA silencing.   
One possible explanation is that SET1 does not significantly 
trimethylate rDNA regions.  Another hypothesis is that contrary to the 
previous model that rDNA silencing requires mono-methylation of H3K4, 
perhaps trimethylation is necessary for silencing.  These hypotheses 
could be tested using rDNA specific H3K4 antibodies for the mono-, di-, 
and tri-methylated forms of H3K4 to see if there is a significant increase 
in trimethylation.   However, it would be best to first verify these results 
using a second rDNA silencing assay to ensure the validity of our results.   
We also examined the literature concerning telomeric silencing 
phenotypes.  Nislow and coworkers report that set1∆ mutants are 
completely sensitive to 5-FOA, indicating a complete (>100,000 fold) 
derepression of URA3 (Figure C-13a).47 We then contacted our 
collaborators and asked them to use yeast strain JDY165, which has 
markers URA3 and ADE2 at telomeric region, and plate them onto SC-
LEU+5-FOA.  The results of this telomeric silencing assay did not 
replicate those reported by Nislow and coworkers (Figure C-13b, Junbiao 
Dai, personal communication).  Since then, our collaborators have 
ordered new primers to check the set1∆ strain to make sure they are 
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correct; and if not, then new set1∆ strains will be made.  Therefore, our 
project is temporarily on hold until new strains are made.   
 
Future Directions 
Currently, we are awaiting news from our collaborators regarding 
the set1∆ strains.  Once they are received, we would like to proceed with 
the biochemical characterization of the three SET1 mutants; N1016A, 
Figure C-13:  
(a) Expected results of telomeric silencing assay.  Taken from 
Nislow and coworkers Figure 4b (1997).   
 
 
(b) Observed results of telomeric silencing assay.   
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R871A, and Y1052F.  Using antibodies for the mono-, di-, and 
trimethylated forms of H3K4, ChIP experiments can be performed to look 
specifically for the H3K4 methylation status of genes found in silenced 
and euchromatic regions.  We expect that N1016A will decrease H3K4 
methylation, R871A will lead to mono-methylation of H3K4, and Y1056F 
will lead to tri-methylation of H3K4 in the ChIP experiments.   
We ultimately hope to discover is whether SET1’s core complex 
will assemble in vivo, or will it be unable to assemble in the absence of 
the crucial arginine residue in mutant R871A.  Understanding this 
question is important because of the involvement of MLL in human 
leukemias.  Little is known about MLL’s enzymatic activity as a 
methyltransferase, and a greater understanding can aid in identifying 
new therapeutic strategies for the treatment of leukemia.   Because 
R3765A inhibits the activity of MLL, perhaps new drugs can be made 
which block the interaction of MLL and WDR5.  Thus, it is important to 
understand the regulation of H3K4 methylation both in vitro and in vivo.   
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